08/26/2025
4:06 PM | Aggarwal Gaurav (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2025
3:30 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2025
4:16 PM | GREAT POINT PARTNERS LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/14/2025
3:38 PM | Nantahala Capital Management, LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/14/2025
7:15 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2025
5:39 AM | Unicycive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2025
3:30 PM | Laumas Sandeep (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2025
3:30 PM | Aggarwal Gaurav (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2025
8:05 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2025
8:25 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2025
3:21 PM | Unicycive Therapeutics (Filer)
| Form 424B5 | |
Get the Latest News and Ratings for UNCY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/10/2025
8:29 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
9:38 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
9:40 AM | Unicycive Therapeutics (Filer)
| Form DEFA14A | |
05/21/2025
7:04 PM | Unicycive Therapeutics (Filer)
| Form DEFA14A | |
05/21/2025
8:17 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2025
8:19 AM | Unicycive Therapeutics (Filer)
| Form DEFA14A | |
05/15/2025
3:39 PM | Nantahala Capital Management, LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/15/2025
7:30 AM | Unicycive Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025
7:01 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
6:05 AM | Unicycive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2025
3:21 PM | Unicycive Therapeutics (Filer)
| Form DEFA14A | |
03/31/2025
8:15 AM | Unicycive Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/19/2025
10:55 AM | Aggarwal Gaurav (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:43 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
3:39 PM | GREAT POINT PARTNERS LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025
2:08 PM | Unicycive Therapeutics (Subject)
Walleye Capital LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/07/2025
3:15 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:31 PM | Nantahala Capital Partners Limited Partnership (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/20/2024
3:32 PM | Nantahala Capital Management, LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/20/2024
11:15 PM | Unicycive Therapeutics (Filer)
| Form EFFECT | |
11/14/2024
11:15 PM | Unicycive Therapeutics (Filer)
| Form EFFECT | |
11/14/2024
6:13 PM | Logos Global Management LP (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
6:01 PM | Unicycive Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
3:53 PM | Nantahala Capital Management, LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/14/2024
3:53 PM | Nantahala Capital Partners Limited Partnership (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/13/2024
4:29 PM | Unicycive Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/13/2024
3:52 PM | Unicycive Therapeutics (Subject)
Walleye Capital LLC (Filed by)
| Form SC 13G | |
11/13/2024
3:05 PM | Unicycive Therapeutics (Filer)
| Form POS AM | |
11/13/2024
7:04 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad) Something big is brewing in Washington.
According to my research, an executive order from President Trump could be just weeks away.
And it holds the potential to trigger one of the most explosive tech booms in US history.
At the center of it all? Robots.
Not the kind that clean your house or pour you coffee.
But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year. This little-known company holds nearly 100 patents and trades for around $7 |
11/13/2024
6:05 AM | Unicycive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
4:15 PM | Aggarwal Gaurav (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:54 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access